Green(er) pharmacy

Green and Sustainable Pharmacy

Volumn , Issue , 2010, Pages 37-59

  Clark, James H ^a   Breeden, Simon W ^a   Summerton, Louise ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860913316     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-05199-9_4     Document Type: Chapter

References (33)

1. Alfonsia K, Colberg J, Dunn PJ, Fevigd T, Jennings S, Johnson TA, Kleine HP, Knight C, Nagy MA, Perry DA, Stefaniakc M (2008) Green chemistry tools to influence a medicinal chemistry and research chemistry based organisation. Green Chem 10, 31-36
2. Anastas P, Warner J (1998) Green Chemistry: Theory and Practice. Oxford University Press, Oxford
3. Andraos J (2005) Unification of reaction metrics for green chemistry II: Evaluation of named organic reactions and application to reaction discovery. Org Process Res Dev 9, 404-431
4. Baran PS, Maimone TJ, Richter JM (2007) Total synthesis of marine natural products without using protecting groups. Nature 446, 404-408
5. Barnard TM, Vanier GS, CollinsMJ (2006) Scale-up of the green synthesis of azacycloalkanes and isoindolines under microwave irradiation. Org Process Res Dev 10, 1233-1237
6. Carey JS, Laffan D, Thomson C, Williams MT (2006) Analysis of the reactions used for the preparation of drug candidate molecules. Org Biomol Chem 4, 2337-2347
7. Chen C-Y, Frey LF, Shultz S, Wallace DJ, Marcantonio K, Payack JF, Vazquez E, Springfield SA, Zhou G, Liu P, Kieczykowski GR, Chen AM, Phenix BD, Singh U, Strine J, Izzo B, Krska SW (2007) Catalytic, enantioselective synthesis of taranabant, a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity. Org Process Res Dev 11, 616-623
8. Clark JH, Smith P (2005) Basic principles of green chemistry. Innov Pharma Technol, 94
9. Clark JH, Tavener SJ (2007) Alternative solvents: Shades of green. Org Process Res Dev 11, 149
10. Connolly TJ, McGarry P, Sukhtankar S (2005) An eco-efficient pilot plant scale synthesis of two 5-Substituted-6,7-Dimethoxy-1-H-Quinazoline-2,4-Diones. Green Chem 7, 586-589
11. Dragovich PS, Prins TJ, Zhou R, Johnson TO, Hua Y, Luu HT, Sakata SK, Brown EL, Maldonado FC, Tuntland T, et al. (2003) Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. J Med Chem 46, 4572-4585
12. Dunn PJ, Galvin S, Hettenbach K (2004) The development of an environmentally benign synthesis of Sildenafil Citrate (viagra) and its assessment by green chemistry metrics. Green Chem 6, 43-52
13. Federsel H-J (2006) In search of sustainability: Process R&D in light of current pharmaceutical industry challenges. Drug Discov Today 11, 966-974
14. Gaunt MJ, Johansson CCC, McNallya A, Voa NT (2007) Enantioselective organocatalysis. Drug Discov Today 12(1/2), 8-27
15. Hjeresen DL, Kirchhoff MM, Lankey RL (2002) Green chemistry: Environment, economics, and competitiveness. Corporate Environ Strategy 9(3), 259-266
16. Jiménez-González C, Constable DJ, Curzons AD, Cunningham VL (2002) Developing GSK's green technology guidance: Methodology for case-scenario comparison of technologies. Clean Tech Environ Policy 4(1), 44-53
17. Jiménez-González C, Overcash M (2000) Energy sub-modules applied in life-cycle inventory of processes. Clean Products Process 2, 57-66
18. Khetan SK, Collins TJ (2007) Human pharmaceuticals in the aquatic environment: A challenge to green chemistry. Chem Rev 107(6), 2319-2364
19. Kümmerer K (2007) Sustainable from the very beginning: Rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry. Green Chem 9, 899-907
20. Kümmerer K (2008) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Springer, Germany
21. Kümmerer K, Al-Ahmad A, Bertram B, WießlerM(2000) Biodegradability of antineoplastic compounds in screening tests: Influence of glucosidation and of stereochemistry. Chemosphere 40, 767-773
22. Kuzemko MA, Van Arnum SD, Henry J, Niemczyk HJ (2007) A green chemistry comparative analysis of the syntheses of (E)-4-Cyclobutyl-2-[2-(3-nitrophenyl) ethenyl] Thiazole, Ro 24-5904. Org Process Res Dev 11, 470-476
23. Lee W, Li Z-H, Vakulenko S, Mobashery S (2000) A light-inactivated antibiotic. J Med Chem 43, 128-132
24. Lipinski CA, Lombardo F, Dominy BF, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46, 3-26
25. Ng R (2004) Drugs: From Discovery to Approval. Wiley-Liss, Hoboken, NJ
26. O'Malley DP, Li K, Maue M, Zografos AL, Baran PS (2007) Total synthesis of dimeric pyrrole-imidazole alkaloids: Sceptrin, Ageliferin, Nagelamide E, Oxysceptrin, Nakamuric acid, and the Axinellamine carbon skeleton. J Am Chem Soc 129, 4762-4775
27. Oprea TI (2002) Current trends in lead discovery: Are we looking for the appropriate properties? J Comput Aided Mol Des 16, 325-334
28. Patrick GL (2001) An Introduction to Medicinal Chemistry. Oxford University Press, Oxford
29. Rouhi M (2002) Green chemistry for pharma. C&EN Sci Technol 80(16), p30-p33
30. Sheldon RA (2007) The E factor 15 years on. Green Chem 9, 1273-1283
31. Tao J, Zhao L, Ran N (2007) Recent advances in developing chemoenzymatic processes for active pharmaceutical ingredients. Org Process Res Dev 11, 259-267
32. Tucker JL (2006) Green chemistry, a pharmaceutical perspective. Org Process Res Dev 10, 315
33. Werpy T, Petersen G (eds.) (2004) Top Value Added Chemicals from Biomass: Volume 1-Results of Screening for Potential Candidates from Sugars and Synthesis Gas. National Renewable Energy Laboratory, Golden, CO